Good morning from Paul & Graham!

Today's report is now finished. Lots more to cover, but I've run out of time & energy!


Explanatory notes -

A quick reminder that we don’t recommend any stocks. We aim to review trading updates & results of the day and offer our opinions on them as possible candidates for further research if they interest you. Our opinions will sometimes turn out to be right, and sometimes wrong, because it's anybody's guess what direction market sentiment will take & nobody can predict the future with certainty. We are analysing the company fundamentals, not trying to predict market sentiment.

We stick to companies that have issued news on the day, with market caps up to about £700m. We avoid the smallest, and most speculative companies, and also avoid a few specialist sectors (e.g. natural resources, pharma/biotech).

A key assumption is that readers DYOR (do your own research), and make your own investment decisions. Reader comments are welcomed - please be civil, rational, and include the company name/ticker, otherwise people won't necessarily know what company you are referring to.


Agenda

Absolutely loads of updates today, plus some backlog items. So we'll focus mainly on short sections, covering as many companies as we can.

Paul's Section:

Cambridge Cognition Holdings (LON:COG) [quick comment] (I hold) - in line with market expectations trading update. Interesting acquisition of Winterlight Labs for £7m (£3m cash, £4m shares with 6m lock-in, c.10% dilution). Acquisition seems to be loss-making, but with exciting-sounding potential - it talks of “major growth”from specialism in speech-based digital biomarkers. Strong order book. Cross-selling opportunities. Sounds interesting, but does this mean the enlarged group will become loss-making again? Does that matter? Will be interesting to see how a market that’s turning more bullish sees this. It could add some spice to the way COG is perceived, if bullish conditions develop further maybe?

Warpaint London (LON:W7L) - another positive trading update, ahead of expectations, from this makeup company that has been on a roll for some time. I work out the valuation (in the absence of broker notes) and think it looks bang in the middle of what seems reasonable. Update - a note from Shore Capital has just come through! Therefore despite a strong run up in share price recently, I think the fundamentals justify & back up…

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here